The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia. - Suppr | 超能文献

The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.

作者信息

Litton Edward

出版信息

Crit Care Resusc. 2015 Jun;17(2):144-5.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.

Crit Care Resusc. 2015 Jun;17(2):144-5.

2

The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.IRONMAN试验：一项针对重症监护病房贫血患者静脉注射铁剂的多中心随机安慰剂对照试验方案。

Crit Care Resusc. 2015 Jun;17(2):144.

3

The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia.IRONMAN 试验：一项多中心随机安慰剂对照试验的方案，研究静脉内铁在重症监护病房贫血患者中的应用。

Crit Care Resusc. 2014 Dec;16(4):285-90.

4

Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.静脉铁剂或安慰剂治疗重症监护贫血：IRONMAN 多中心随机双盲试验：重症疾病中 IV 铁剂的随机试验。

Intensive Care Med. 2016 Nov;42(11):1715-1722. doi: 10.1007/s00134-016-4465-6. Epub 2016 Sep 30.

5

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.静脉注射蔗糖铁在纠正炎症性肠病（IBD）患者贫血及恢复铁储备方面优于口服硫酸亚铁：一项随机、对照、评估者盲法、多中心研究。

Scand J Gastroenterol. 2009;44(7):838-45. doi: 10.1080/00365520902839667.

6

Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: treatment of anaemia with iron.《欧洲慢性肾衰竭患者贫血管理最佳实践修订指南》第三部分.2：铁剂治疗贫血

Nephrol Dial Transplant. 2005 Jul;20(7):1512-3; author reply 1513-4. doi: 10.1093/ndt/gfh976.

7

Anemia in the critically ill: do we need to live with it?*.危重症患者的贫血：我们是否需要与之共存？*

Crit Care Med. 2014 Sep;42(9):2140-1. doi: 10.1097/CCM.0000000000000463.

8

Hepcidin as a target of therapy in the treatment of anemia after trauma.铁调素作为创伤后贫血治疗的靶点。

Crit Care Med. 2015 Jan;43(1):e36-7. doi: 10.1097/CCM.0000000000000689.

9

The author replies.作者回复。

Crit Care Med. 2015 Jan;43(1):e37. doi: 10.1097/CCM.0000000000000737.

10

Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.自体造血细胞移植后使用达贝泊汀α和静脉铁剂的随机试验的长期安全性随访

Am J Hematol. 2015 Jul;90(7):E133-4. doi: 10.1002/ajh.24013.

引用本文的文献

1

Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness.静脉铁剂或安慰剂治疗重症监护贫血：IRONMAN 多中心随机双盲试验：重症疾病中 IV 铁剂的随机试验。

Intensive Care Med. 2016 Nov;42(11):1715-1722. doi: 10.1007/s00134-016-4465-6. Epub 2016 Sep 30.